Peter Lynch fit · Growth at a reasonable price (GARP)
Is TG Therapeutics, Inc. (TGTX) a Peter Lynch Stock?
Strong GARP candidate - growth at a reasonable price.
80/100
ALikely Lynch stock
1/6 criteria passed
+8 sector-quality lift. Top-quintile within its sector on 4 of 5 quality metrics. Raw pillar score 72 → lifted to 80 before grade derivation.
Peter Lynch's Criteria, Applied to TGTX
PEG ≤ 1.0
key-
EPS CAGR ≥ 15%
key-
Revenue CAGR ≥ 10%
-
Net margin > 0
66.0%
How TGTX Scores on Other Strategies
Live Financial Snapshot
Market cap
$8.25B
P/E (TTM)
12.4x
ROIC (TTM)
11.13%
Gross margin
83.04%
Other Peter Lynch fit reports
Frequently Asked Questions
What is TGTX's Peter Lynch fit score?
TGTX scores 80/100 on our Peter Lynch fit engine - grade A. Strong GARP candidate - growth at a reasonable price.
Does Peter Lynch actually own TGTX?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends TGTX.
How often is this score updated?
TGTX's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Peter Lynch personally owns or recommends TGTX.